FDA Inspection
Hospira Zagreb d.o.o.Hospira Zagreb d.o.o. – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Hospira Zagreb d.o.o., with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · 53387c32-9209-49d8-9c4d-defc024a571e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1123692
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hospira Zagreb d.o.o.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hospira Zagreb d.o.o.
- FDA Inspection 1225278 - 2023-11-07
- FDA Inspection 1226933 - 2021-12-16
- FDA Inspection 1051780 - 2018-02-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.